{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:34:24Z","timestamp":1760016864270},"reference-count":10,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2007,7,19]],"date-time":"2007-07-19T00:00:00Z","timestamp":1184803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2008,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Targeted broadband ultraviolet B (UVB) phototherapy as well as 308\u2010nm excimer laser have been reported to significantly improve or clear localized psoriatic plaques within 5 to 10 treatments when medium fluences [i.e. 4\u20136 multiples of minimal erythema doses (MED)] were used. Our study was conducted to determine the effects of different concentrations of topical 8\u2010methoxypsoralen (8\u2010MOP) cream when used in combination with targeted UV phototherapy with regard to number of treatments and cumulative UV doses to clear localized psoriasis. Ten evaluable patients with stable plaque\u2010type psoriasis completed the study. Three different concentrations of 8\u2010MOP creams (0.001%, 0.01% and 0.1%) were applied prior to irradiation with 4 MEDs of targeted narrowband UVB (NB\u2010UVB), whereas 0.001% 8\u2010MOP cream was used in conjunction with 5\u00a0J\/cm<jats:sup>2<\/jats:sup> UVA. All irradiations took place once weekly for 12\u00a0weeks. Psoriasis severity index (PSI) score was used to evaluate the efficacy of the treatment. With area\u2010under\u2010the\u2010curve analysis, 0.1% 8\u2010MOP\/NB\u2010UVB was superior to other modalities in reducing the PSI scores. The number of treatments and cumulative NB\u2010UVB doses necessary to achieve PSI\u201095, a 95% reduction in the scores, was also lower in the 0.1% 8\u2010MOP\/NB\u2010UVB group, although the differences were not statistically significant. We conclude that topical 8\u2010MOP cream enhances the therapeutic effects of targeted NB\u2010UVB phototherapy without significantly increasing the short\u2010term adverse effects.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2007.02328.x","type":"journal-article","created":{"date-parts":[[2007,7,19]],"date-time":"2007-07-19T12:50:24Z","timestamp":1184849424000},"page":"50-55","source":"Crossref","is-referenced-by-count":19,"title":["Topical 8\u2010methoxypsoralen enhances the therapeutic results of targeted narrowband ultraviolet B phototherapy for plaque\u2010type psoriasis"],"prefix":"10.1111","volume":"22","author":[{"given":"P","family":"Asawanonda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Amornpinyokeit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Nimnuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,12,20]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.141.12.1542"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.125075"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.1999.tb00063.x"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb16956.x"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1159\/000066251"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1993.tb00174.x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06533.x"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120454"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.6.759"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06320.x"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2007.02328.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2007.02328.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T06:31:56Z","timestamp":1697005916000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2007.02328.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,20]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["10.1111\/j.1468-3083.2007.02328.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2007.02328.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,20]]}}}